{
  "REG_COMPANY_ENROL": "Regulatory Company Enrolment",
  "LOAD_COMPANY_FILE": "Load a Company Enrolment File",
  "ENROL_INSTRUCT": "Company Regulatory Enrolment Instructions",
  "ADDRESS_INSTRUCT":"Company Address Record Instructions",
  "ADDRESS_ROLE_INSTRUCT":"Company Address Role Instructions",
  "REPRESENT_INSTRUCT":"Company Representative Information",
  "SAVE_INSTRUCT": "Company File Save Instructions",
  "AMEND_NOTE": "The “Amend Enrolment” button must be selected when amending a Final Company XML.",
  "FIELDID": "Company Identifier",
  "IMPORTERID":"Importer Company Identifier",
  "COMPANY_NAME": "Company Name",
  "HT_LOAD_FILE_1": "A file should not be loaded if it is the first REP transaction for this dossier.",
  "HT_LOAD_FILE_2": "When continuing with a working copy, the format of the file to load should be .hcsc.",
  "HT_LOAD_FILE_3": "When viewing/updating a final XML file, the format of the file to load should be .xml.",
  "ENROL_1.0": " The “Enrolment Status”, “Enrolment Version”, and “Date Last Saved” fields are automatically filled by the form upon selecting “Save Working Copy” or “Save Draft XML” in the bottom of the template. ",
  "ENROL_2.0": "The “Company Identification” field will be filled by Health Canada when they generate the final company XML file.",
  "ENROL_3.0": "The “Amend Enrolment” button is only enabled when a final company xml file is loaded into the template, and must be selected when amending a final company XML file.",
  "ADDR_INFO_1": "A minimum of one address is required for the company template.",
  "ADDR_INFO_2.0": "There must be an address associated with each of the following three roles: “Manufacturer / Sponsor Mailing Address”, “Billing Address”, and “Regulatory Mailing / Annual Contact Address”.",
  "ADDR_INFO_3": "A single address may be associated to multiple roles, however, each role may only have one address.",
  "BUS_NUM_4.0": "A business number is a unique, 9-digit number (i.e., the standard identifier for businesses). It is unique to a business or legal entity.Information on the business number can be found on the ",
  "BUS_NUM_4.1": "https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/registering-your-business/you-need-a-business-number-a-program-account.html",
  "BUS_NUM_4.2": "Government of Canada website",
  "ROLE_1": "“Manufacturer / Sponsor Address”: Refers to the name under which the drug submission is filed, where a Drug Identification Number (DIN) / Notice of Compliance (NOC) is to be issued, the company in whose name the DIN / NOC will be registered, (i.e., the DIN / NOC owner), and the name to be included on the product label and Product Monograph / Package Insert.",
  "ROLE_2": "“Regulatory Mailing / Annual Contact Address”: Pertains to where and to whom Health Canada should direct regulatory mail other than correspondence specific to the subject drug submission, e.g. annual notification, regulatory / policy amendment notices as they apply to DINs registered to the manufacturer/sponsor. Operational and system requirements dictate that the regulatory mailing name/address must be the same for all DINs registered to the manufacturer / sponsor identified where more than one DIN is held by that company.",
  "ROLE_3": "“Billing Address”: To whom the invoice is to be sent.",
  "ROLE_4": "“Canadian Importer Mailing Address”: is responsible for the sale of products in Canada when the sponsor/manufacturer identified is NOT located in Canada. Although it does not need to be provided at the time of initial company enrolment, the Canadian Importer responsible for sale must be identified prior to the product entering the market. Add a Canadian Importer Mailing Address to the Company XML file by using the “amend enrolment” button. The Importer Company Identifier issued by Health Canada should also be referred to in the Product Information XML file, where appropriate.",
  "COMPANY_REP_1": "A minimum of one company representative is required for the company template.",
  "COMPANY_REP_2": "There must be a company representative associated with each of the following roles: “Manufacturer / Sponsor Contact”, “Billing Contact”, “Regulatory Mailing / Annual Contact” and “Primary Regulatory Enrolment Process contact”.",
  "COMPANY_REP_3": "If there is a company representative associated with the Canadian importer, sponsors may choose to provide it, however, it is not a requirement",
  "COMPANY_REP_4": "A single contact may be associated with multiple roles, however, each role may only have one contact.",
  "COMPANY_REP_5": "The Primary REP contact is the person to be contacted by Health Canada if there are any issues or clarifications required for this template when it is submitted for approval.",
  "COMPANY_REP_6": "Description of Roles",
  "COMPANY_REP_7": "“Manufacturer / Sponsor Contact”: Refers to the name to which the drug submission is filed and, where a Drug Identification Number (DIN) / Notice of Compliance (NOC) is to be issued, the company in whose name the DIN / NOC will be registered, (i.e., the DIN / NOC owner) and the name to be included on the product label and Product Monograph / Package Insert.",
  "COMPANY_REP_8": "“Regulatory Mailing / Annual Contact”: Pertains to where and to whom Health Canada should direct regulatory mail other than correspondence specific to the subject drug submission, e.g. annual notification, regulatory / policy amendment notices as they apply to DINs registered to the manufacturer/sponsor. Operational and system requirements dictate that the regulatory mailing name/address must be the same for all DINs registered to the manufacturer / sponsor identified where more than one DIN is held by that company.",
  "COMPANY_REP_9": "“Billing Contact”: To whom the invoice is to be sent.",
  "COMPANY_REP_10": "“Canadian Importer mailing address”: Is responsible for the sale of products in Canada when the sponsor/manufacturer identified is NOT located in Canada. ",
  "ROUTING_ID_1": "The routing identifier is a unique identifier within the Electronic Submissions Gateway (ESG) for each account, used to identify the specific gateway account, whether it uses the Applicability Statement 2 (AS2) or WebTrader interfaces.",
  "ROUTING_ID_2": "For the WebTrader users, the routing identifier is automatically assigned to each account by the system. It can be retrieved from any message disposition notification receipt, under attribute: “X-Cyclone-To:” ",
  "ROUTING_ID_3": "For AS2 users, the routing identifier has to be created by the company. It is recommended that the company's data universal numbering system number be used for this, but any alpha-numeric text string is acceptable.",
  "ROUTING_ID_4.0": "For any further questions on the routing identifier, please contact the ",
  "ROUTING_ID_4.1": "mailto:ESGHelpDesk@fda.hhs.gov",
  "ROUTING_ID_4.2": "Food and Drug Administration Help Desk",
  "ROUTING_ID_5": "The routing identifier could be the same for the manufacturer / sponsor contact and regulatory / annual contact. The Canadian importer would have a separate routing identifier.",
  "COMPANY_ROLE_1": "The Primary Regulatory Enrolment Process (REP) contact is the person to be contacted by Health Canada if there are any issues or clarifications required for this template when it is submitted for enrolment or amendment.",
  "GEN_XML_1": "Submit the draft XML file to Health Canada using the Common Electronic Submission Gateway (CESG).",
  "GEN_XML_2": "Refer to the Regulatory Enrolment Process (REP) guidance document for detailed information."
}